Sidipin B | 133849-24-8

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: Sidipin B
• 英文别名: Nα-palmitoyl-lysine；N-palmitoyllysine；palmitoyl-lysine；n-Palmitoyl lysine；6-amino-2-(hexadecanoylamino)hexanoic acid
• CAS: 133849-24-8
• 化学式: C₂₂H₄₄N₂O₃
• 分子量: 384.603
• InChiKey: OLDGKSQBWGEFNM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  27
• 可旋转键数：
  20
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.91
• 拓扑面积：
  92.4
• 氢给体数：
  3
• 氢受体数：
  4

文献信息

• Charged sophorolipids and sophorolipid containing compounds
  申请人：Zerkowski Jonathan

  公开号：US20070027106A1

  公开（公告）日：2007-02-01

  A sophorolid produced by a method involving reacting a compound of formula I with a compound of formula II wherein R 1 and R 2 are H, C 1 -C 18 alkyl, C 3 -C 18 alkenyl, C 3 -C 10 cycloalkyl, phenyl, or C 1 through C 18 acyl or alkoxycarbonyl, R 1 and R 2 are not both acyl, R 3 is H, CH 3 , CH 2 -phenyl, CH 2 —C 6 H 4 —OH, CH 2 CO 2 H, CH 2 CH 2 CO 2 H, CH(CH 3 ) 2 , CH 2 CH(CH 3 ) 2 , CH(CH 3 )CH 2 CH 3 , CH 2 OH, CH(CH 3 )OH, CH 2 CH 2 CH 2 CH 2 NH 2 , CH 2 CH 2 CONH 2 , CH 2 CONH 2 , CH 2 —C 3 N 2 H 3 (histidine), CH 2 CH 2 CH 2 NHC(NH)NH 2 , CH 2 CH 2 SCH 3 , R 2 and R 3 may be joined in a ring, R 4 is H, C 1 -C 18 alkyl, C 3 -C 18 alkenyl, C 3 -C 10 cycloalkyl, or phenyl, n is 0-6, R 5 and R 6 are H, C 1 -C 18 alkyl, C 3 -C 18 alkenyl, C 3 -C 10 cycloalkyl, or phenyl, and X is C 1 -C 18 alkyl or C 1 -C 18 alkenyl; optionally followed by acidolytic (treating with an acid) or hydrogenolytic deprotection (treating with a hydrogenolysis catalyst) which removes one of the groups R 1 or R 2 and replaces it with hydrogen. Also a sophorolipid containing composition containing a carrier and at least one sophorolipid described above.

  通过一种涉及将式I化合物与式II化合物反应的方法生产的一种索福罗脂，其中R1和R2为H、C1-C18烷基、C3-C18烯基、C3-C10环烷基、苯基或C1-C18酰基或烷氧羰基，R1和R2不同时为酰基，R3为H、CH3、CH2-苯基、 —C6H4—OH、 CO2H、 CO2H、CH( )2、 CH( )2、CH( ) 、 OH、CH( )OH、 NH2、 CONH2、 CONH2、 —C3N2H3（组氨酸）、 NHC(NH)NH2、 S ，R2和R3可连接成环，R4为H、C1-C18烷基、C3-C18烯基、C3-C10环烷基或苯基，n为0-6，R5和R6为H、C1-C18烷基、C3-C18烯基、C3-C10环烷基或苯基，X为C1-C18烷基或C1-C18烯基；可选择性地接着酸解（用酸处理）或氢解保护（用氢解催化剂处理），去除R1或R2中的一个基团，并用氢替换之。还有一种含有载体和上述至少一种索福罗脂的索福罗脂含有组合物。
• Surface modification using N-acyl lysines
  申请人：AJINOMOTO CO., INC.

  公开号：EP0139481A2

  公开（公告）日：1985-05-02

  There is disclosed a formulation comprising a base component in combination with one or more organic component chosen from N-mono- and N,N-di-acylated basic amino acids, wherein the acyl group in the N-mono-acylated basic amino acid is an aliphatic acyl group having from 8 to 22 carbon atoms, and each of the acyl groups, which may be the same or different, in the N,N-di-acylated basic amino acid is an aliphatic acyl group having from 1 to 22 carbon atoms with the proviso that the two aliphatic acyl groups together have from 9 to 44 carbon atoms. The formulation is useful in novel cosmetics and as a novel surface-modified inorganic filler.

  本发明公开了一种制剂，该制剂由基质成分与一种或多种选自 N-单-和 N,N-二-酰化碱性氨基酸的有机成分组合而成，其中 N-单-酰化碱性氨基酸中的酰基是具有 8 至 22 个碳原子的脂肪族酰基、N,N-二乙酰化碱性氨基酸中的每个酰基（可以相同或不同）都是具有 1 至 22 个碳原子的脂肪族酰基，但这两个脂肪族酰基加在一起具有 9 至 44 个碳原子。 该配方可用于新型化妆品和新型表面改性无机填料。
• Fluorescence polarization method for monitoring fetal lung maturity
  申请人：ABBOTT LABORATORIES

  公开号：EP0253271A1

  公开（公告）日：1988-01-20

  The present invention is directed to a fluorescence polarization method for monitoring fetal lung maturity, to various components needed for preparing and carrying out such monitoring, and to methods of making these components.

  本发明涉及一种用于监测胎儿肺成熟度的荧光偏振方法、制备和实施这种监测所需的各种元件以及制造这些元件的方法。
• Sulfonium compounds, as well as process for producing active esters and amides used for the production of amides
  申请人：SANSHIN KAGAKU KOGYO CO., LTD.

  公开号：EP0331988A1

  公开（公告）日：1989-09-13

  In the present invention an amide represented by the general formula: is produced using a sulfonium salt represented by the general formula: as the starting material, to synthesizing a novel compound, i.e., an active ester represented by the general formula: and further reacting the active ester with a nucleophilic agent represented by the general formula: H-B-Y wherein R1 represents a hydrogen, an alkyl group or a halogen group; R2 and R3, which may be same or different, each represents an alkyl group; X- represents an anion typified by a halogen ion, a perchloric acid ion, a hydrogen sulfuric acid ion, a methylsulfuric acid ion, and a p-toluenesulfonic acid ion; W represents an alkyl group, alkoxy group group, in which R4. represents a halogen, a hydrogen or a methoxy or a Ci - C5 alkyl group substituted with 1 - 3 halogen atoms, an aryl group or a fluorenylmethoxy group, or represents, together with W- C -, an amino acid, a peptide, or a protein group, in which the terminal amino group and the side chain group of the amino acid has or has not a protective group, B represents a substituted or not-substituted imino group, Y represents an organic group or B and Y join together to represent a heterocyclic amine. Alternatively H-BY represents an amino acid in which a proper protective group is or is not introduced into a-carboxyl group and/or side chain, or a peptide or protein in which a proper protective group is or is not introduced into the terminal carboxyl group and/or side chain.

  在本发明中，使用通式为 代表的酰胺作为起始原料，使用通式： 作为起始原料，合成一种新型化合物，即通式： 所代表的活性酯： 并进一步将该活性酯与通式： 所代表的亲核剂反应：H-B-Y 其中 R1 代表氢、烷基或卤素基团；R2 和 R3 可以相同或不同，各自代表烷基；X- 代表卤素离子、高氯酸离子、氢硫酸离子、甲硫 酸离子和对甲苯磺酸离子等类型的阴离子；W 代表烷基、烷氧基和烷烃基团。 其中 R4. 代表卤素、氢或甲氧基或被 1 - 3 个卤素原子取代的 Ci - C5 烷基、芳基或芴甲氧基，或与 W- C - 一起代表氨基酸、肽或蛋白质基团，其中 氨基酸的末端氨基和侧链基团具有或不具有保护基团；B 代表取代或未取代的亚氨基；Y 代表有机基团或 B 和 Y 连接在一起代表杂环胺。或者，H-BY 代表在羧基和/或侧链中引入或未引入适当保护基团的氨基酸，或在末端羧基和/或侧链中引入或未引入适当保护基团的肽或蛋白质。
• Lipopeptides inducteurs des lymphocytes T cytotoxiques et utilisation comme vaccins
  申请人：INSTITUT PASTEUR DE LILLE

  公开号：EP1065212A2

  公开（公告）日：2001-01-03

  L'invention concerne l'utilisation pour la fabrication d'un médicament pour l'immunisation du corps humain ou animal à l'encontre d'agents pathogènes ou de cellules tumorales de lipopeptides comprenant une partie peptidique ayant entre 10 et 40 acides aminés environ et comportant au moins un déterminant antigénique induisant spécifiquement des lymphocytes T cytotoxiques. Les lipopeptides comprennent également une ou plusieurs chaînes dérivées de la N-ε-palmitoyl-lysine couplées sur des fonctions carboxyle desdits acides aminés.

  本发明涉及使用脂肽制造用于人体或动物体免疫抗病原体或肿瘤细胞的药物产品，脂肽由肽部分组成，该肽部分具有约 10 至 40 个氨基酸，并包含至少一个专门诱导细胞毒性 T 淋巴细胞的抗原决定因子。脂肽还包括一条或多条由 N-ε-棕榈酰-赖氨酸衍生的链，这些链与上述氨基酸的羧基功能相耦合。